Meeting
2012 ASCO Annual Meeting
The role of phase I clinical trials in advanced malignant melanoma: Retrospective analysis of CTEP-sponsored trials 1995-2011.
Authors
Jason John Luke
Dana-Farber Cancer Institute, Boston, MA
Jason John Luke , Larry Rubinstein , Gary L Smith , S. Percy Ivy , Pamela Jo Harris
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics - Clinical Pharmacology and Immunotherapy
Track
Developmental Therapeutics
Sub Track
Other
Citation
J Clin Oncol 30, 2012 (suppl; abstr 2606)
DOI
10.1200/jco.2012.30.15_suppl.2606
Abstract #
2606
Poster Bd #
9G
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
Clinical outcome of patients with metastasic melanoma undergoing phase I clinical trials.
First Author: M. Blanco-Codesido
Poster
2023 ASCO Annual Meeting
Role of nivolumab maintenance therapy in advanced melanoma patients following severe immune-related adverse events from combination nivolumab and ipilimumab.
First Author: Anna Maloney
Poster
2022 ASCO Annual Meeting
Fecal microbiota transplantation followed by anti–PD-1 treatment in patients with advanced melanoma.
First Author: Wilson H. Miller Jr.
Poster
2021 ASCO Annual Meeting
Phase I trial of acoustic cluster therapy (ACT) with chemotherapy in patients with liver metastases of gastrointestinal origin (ACTIVATE study).
First Author: Udai Banerji